Strikingly, we found interesting differences in the expression levels of several components of the ECS in different brain regions and between sex, which could indicate that the ECS is already altered in APP/PS1 mice at presymptomatic stages becoming an early event contributing to AD pathology or a potential predictive biomarker. Here, APP is linked to Alzheimer disease.